# | Title | Journal | Year | Citations |
---|
1 | Epstein–Barr Virus Infection | New England Journal of Medicine | 2000 | 1,424 |
2 | Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention | New England Journal of Medicine | 1996 | 623 |
3 | Varicella zoster virus infection | Nature Reviews Disease Primers | 2015 | 435 |
4 | The Chronic Mononucleosis Syndrome | Journal of Infectious Diseases | 1988 | 371 |
5 | Latent Herpes Simplex Virus in Human Trigeminal Ganglia | New England Journal of Medicine | 1987 | 365 |
6 | VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease | Science | 2019 | 344 |
7 | Roles for Endocytosis and Low pH in Herpes Simplex Virus Entry into HeLa and Chinese Hamster Ovary Cells | Journal of Virology | 2003 | 308 |
8 | Priming of protective T cell responses against virus-induced tumors in mice with human immune system components | Journal of Experimental Medicine | 2009 | 269 |
9 | Acyclovir Treatment of the Chronic Fatigue Syndrome | New England Journal of Medicine | 1988 | 226 |
10 | Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes | Lancet, The | 1994 | 214 |
11 | Acyclovir-induced renal failure | American Journal of Medicine | 1988 | 209 |
12 | Herpes Simplex Virus Type 1 Enters Human Epidermal Keratinocytes, but Not Neurons, via a pH-Dependent Endocytic Pathway | Journal of Virology | 2005 | 207 |
13 | Cellular and Viral Requirements for Rapid Endocytic Entry of Herpes Simplex Virus | Journal of Virology | 2004 | 190 |
14 | Recurrent Acyclovir-Resistant Genital Herpes in an Immunocompetent Patient | New England Journal of Medicine | 1993 | 165 |
15 | An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor | Proceedings of the National Academy of Sciences of the United States of America | 2008 | 162 |
16 | Glycoprotein D Receptor-Dependent, Low-pH-Independent Endocytic Entry of Herpes Simplex Virus Type 1 | Journal of Virology | 2005 | 157 |
17 | Quantitation of Latent Varicella-Zoster Virus and Herpes Simplex Virus Genomes in Human Trigeminal Ganglia | Journal of Virology | 1999 | 145 |
18 | Mapping of two varicella-zoster virus-encoded genes that activate the expression of viral early and late genes | Virology | 1989 | 141 |
19 | Varicella-Zoster Virus Transcription in Human Trigeminal Ganglia | Virology | 1993 | 138 |
20 | Laser-Capture Microdissection: Refining Estimates of the Quantity and Distribution of Latent Herpes Simplex Virus 1 and Varicella-Zoster Virus DNA in Human Trigeminal Ganglia at the Single-Cell Level | Journal of Virology | 2005 | 134 |
21 | Chronic Active Epstein–Barr Virus Disease | Frontiers in Immunology | 2017 | 132 |
22 | Epstein–barr virus vaccines | Clinical and Translational Immunology | 2015 | 128 |
23 | Allergy and the chronic fatigue syndrome | Journal of Allergy and Clinical Immunology | 1988 | 125 |
24 | Comparative Biology of Latent Varicella-Zoster Virus and Herpes Simplex VirusInfections | Journal of Infectious Diseases | 1992 | 114 |
25 | The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter. | Molecular and Cellular Biology | 1994 | 111 |
26 | Epstein-Barr Virus BARF1 Protein Is Dispensable for B-Cell Transformation and Inhibits Alpha Interferon Secretion from Mononuclear Cells | Journal of Virology | 1999 | 111 |
27 | Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines | Blood | 2021 | 110 |
28 | Lymphocyte phenotype and function in the chronic fatigue syndrome | Journal of Clinical Immunology | 1993 | 107 |
29 | Progressive encephalitis three months after resolution of cutaneous zoster a patient with AIDS | Annals of Neurology | 1986 | 103 |
30 | Genome Differences among Varicella-Zoster Virus Isolates | Journal of General Virology | 1983 | 101 |
31 | Comparative Efficacy and Immunogenicity of Replication-Defective, Recombinant Glycoprotein, and DNA Vaccines for Herpes Simplex Virus 2 Infections in Mice and Guinea Pigs | Journal of Virology | 2005 | 101 |
32 | Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1 | Journal of Virology | 1988 | 95 |
33 | Varicella-zoster virus open reading frame 61 protein is functionally homologous to herpes simplex virus type 1 ICP0 | Journal of Virology | 1992 | 95 |
34 | Bortezomib Induces Apoptosis of Epstein-Barr Virus (EBV)-Transformed B Cells and Prolongs Survival of Mice Inoculated with EBV-Transformed B Cells | Journal of Virology | 2007 | 91 |
35 | Rates of Reactivation of Latent Herpes Simplex Virus from Mouse Trigeminal Ganglia Ex Vivo Correlate Directly with Viral Load and Inversely with Number of Infiltrating CD8 + T Cells | Journal of Virology | 2007 | 91 |
36 | Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome | Journal of Allergy and Clinical Immunology | 2010 | 87 |
37 | Varicella-zoster virus open reading frame 10 protein, the herpes simplex virus VP16 homolog, transactivates herpesvirus immediate-early gene promoters | Journal of Virology | 1993 | 83 |
38 | The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside | Virology | 2015 | 80 |
39 | Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA | Journal of Virology | 1995 | 79 |
40 | Infection of Human T Lymphocytes with Varicella-Zoster Virus: an Analysis with Viral Mutants and Clinical Isolates | Journal of Virology | 2000 | 77 |
41 | Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and delays development of EBV lymphomas | Proceedings of the National Academy of Sciences of the United States of America | 2004 | 77 |
42 | Severe Viral Infections and Primary Immunodeficiencies | Clinical Infectious Diseases | 2011 | 77 |
43 | Varicella-zoster virus open reading frame 4 encodes a transcriptional activator that is functionally distinct from that of herpes simplex virus homology ICP27 | Journal of Virology | 1994 | 77 |
44 | Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro | Journal of Virology | 1994 | 76 |
45 | Varicella-zoster virus (VZV) open reading frame 61 protein transactivates VZV gene promoters and enhances the infectivity of VZV DNA | Journal of Virology | 1993 | 74 |
46 | The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22 | Journal of Virology | 1995 | 74 |
47 | History of Chronic Fatigue Syndrome | Clinical Infectious Diseases | 1991 | 73 |
48 | The murine gammaherpesvirus-68 M11 protein inhibits Fas- and TNF- induced apoptosis | Journal of General Virology | 1999 | 72 |
49 | Identification of Viral MicroRNAs Expressed in Human Sacral Ganglia Latently Infected with Herpes Simplex Virus 2 | Journal of Virology | 2010 | 71 |
50 | Binding of FADD and Caspase-8 to Molluscum Contagiosum Virus MC159 v-FLIP Is Not Sufficient for Its Antiapoptotic Function | Journal of Virology | 2002 | 69 |